REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Surrogate Endpoints and Biomarkers | Basicmedical Key
Surrogate Endpoint | Definitive Healthcare
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases - Incacare
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework | Nature Reviews Drug Discovery
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
Pharmacodynamic markers and surrogate endpoints are a subset of... | Download Scientific Diagram
Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures | Infection Control & Hospital Epidemiology ...
Surrogate markers of infection: interrogation of the immune system | Biomarkers in Medicine
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
JCM | Free Full-Text | Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice?
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Table I from Surrogate markers in HIV disease. | Semantic Scholar
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Example 1: Continuous Surrogate Marker • OptimalSurrogate
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Diagnostics | Free Full-Text | Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
